Kevin M Chan MD
Critical Care Medicine, Lung Transplantation Medicine, Pleural Disease
Professor, Internal Medicine, University of Michigan Medical School
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Fax+1 734-615-5348
Dr. Chan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kevin Chan is a pulmonologist based in Ann Arbor, MI, with subspecialties in Critical Care Medicine, Lung Transplantation Medicine, and Pleural Disease. He completed his fellowship in Pulmonary Disease and Critical Care Medicine at UCLA David Geffen School of Medicine/UCLA Medical Center and residency in Internal Medicine at Rush University Medical Center. Dr. Chan is experienced in managing pneumonia and lung transplantation. He has contributed several publications to reputable journals, focusing on lung transplantation and pulmonary conditions, with works cited multiple times. Additionally, he has been recognized as a Regional Top Doctor by Castle Connolly and received the CMS Meaningful Use Stage 1 Certification. Dr. Chan has participated in a clinical trial on idiopathic pulmonary fibrosis.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1990 - 1993
Rush University Medical CenterResidency, Internal Medicine, 1987 - 1990
Wayne State University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1991 - Present
MI State Medical License 1997 - 2028
IL State Medical License 1990 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled Trials.Derek E Byers, Ramsey Hachem, Chadi A Hage, Rajat Walia, Hilary Goldberg
Transplantation Direct. 2025-10-01 - Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criter...Derek E Byers, Ramsey Hachem, Chadi A Hage, Rajat Walia, Hilary Goldberg
Transplantation. 2025-09-24 - 1 citationsImpact of tacrolimus vs cyclosporine on chronic lung allograft dysfunction incidence and allograft survival in the International Society of Heart and Lung Transplantat...Michael P Combs, Krysta Walter, Haley Hixson, Elizabeth A Belloli, Matthew S Najor
The Journal of Heart and Lung Transplantation. 2025-03-01
Press Mentions
- One Year Later: Michigan Medicine’s First COVID-19 PatientMarch 10th, 2021
Marjan Mikel: Supporting the Management of Chronic Respiratory ConditionsAugust 5th, 2023
Committees
- Pulmonary Specialty Board Member, American Board of Internal Medicine
Professional Memberships
- Fellow
- Member
- International Society of Heart and Lung TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
